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ABSTRACT 
INDRODUCTION 
 Pityriasis versicolor, a mild, chronic superficial, cutaneous mycosis 
caused by Malassezia species is characterised by discrete or confluent, scaly, 
discoloured areas mainly on the upper trunk and other seborrheic areas. This 
infection commonly occurs in adolescents and young adults.  
AIMS AND OBJECTIVES 
• To study the epidemiology of pityriasis versicolor. 
• To study the various clinical types. 
• To study the association of pityriasis versicolor with other dermatological 
disorders and systemic diseases 
• To identify the various species of Malassezia 
• To study the clinicomycological correlation. 
MATERIALS AND METHODS 
            100 patients with pityriasis versicolor were randomly selected. Detailed 
history was taken and clinical examination was done. Scraping was done for all 
the patients KOH positive scrapings were subjected to culture in SDA with 
olive oil overlay. Tween assimilation was done from positive cultures and 
species isolation  done. Gram staining was done from positive cultures. 
OBSEVATION AND RESULTS  
 Pityriasis versicolor is most commonly seen in the age group between 21- 
30years.Males outnumbered the females. PV was more common among the 
students.Urban population was affected more than the rural 
population.Cosmetic concern was the main complaint. Duration of lesion in 
majority of the patients was 1 to 6 months. Diabetes and Seborrheic dermatitis 
was found to be the most commonly associated. Blood group A was commonly 
affected. Most common site was back and majority of the patients had more 
than 30%BSA.Achromicpityriasis versicolor was more 
common.Malasseziaglobosa was the most common species isolated. 
CONCLUSION 
 There is no significant change in clinico-epidemiology and presentation 
of pityriasis versicolor.A blood group was the most common blood group 
associated with pityriasis versicolor which is different from the previous study 
in which O blood group is the commonest association. Hence, further studies in 
a larger population would provide more conclusive evidence with regard to the 
blood groups. 
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INTRODUCTION 
           Pityriasis versicolor, a mild, chronic superficial, cutaneous mycosis 
caused by Malassezia species is characterised by discrete or confluent, scaly, 
discoloured areas mainly on the upper trunk and other seborrheic areas. This 
infection commonly occurs in adolescents and young adults. 1 
             The genus Malassezia is a superficial, dimorphic, lipophilic fungi 
which exists in yeast form in the normal skin flora of the human body. Under 
special circumstances, they get transformed in to mycelial form and produce 
infection. Rarely, they become invasive and cause opportunistic systemic 
infection. In the past two decades, Malassezia species is gaining importance. 
The nomenclature has been changed, newer species have been identified and 
associations of the organism with different disease entities have been 
described. 2 
         The mycelial phase of the fungus is predominant in the lesions. 
Malassezia globosa is the predominant species isolated. M. globosa has been 
isolated in more than 90% cases in various studies. In a study by Gurumohan 
Singh et al, M. globosa was isolated in 60% of patients with pityriasis 
versicolor (PV), and in an additional 37%, in combination with M. 
sympodialis and M. restricta. More than one species of Malassezia can be 
isolated from a single clinical specimen.3 
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The chronic relapsing course of the disease and increased incidence of 
PV among patients on steroids and immunosuppressed patients are suggestive 
of failure on the host mechanism to mount a protective CMI response against 
the fungus. However, during active disease, they fail to generate a CMI 
response that would provide protection.3 
The predisposing factors are warm climate, increased sweating, 
pregnancy, oral contraceptive pills, endocrine disorders and 
immunosuppressive states.1 
      The net outcome of the disease is determined by fungus – host   
relationship. This is particularly  significant  in  the present era of advanced 
medical facilities, where the number of immunocompromised hosts is on the 
rise. 4 
The recognition  of the significance  of Malassezia  has not been 
appreciated previously due to the difficulty in the isolation of these 
lipophilic yeasts in the routine laboratory setting.  In the recent years, 
research on this genus has been expedited by the introduction of molecular 
methods, which have contributed to the understanding of its epidemiology, 
pathogenesis and management by robust interventional   strategies,   given  
that  these  yeasts  are  not  only  involved   in superficial infections, but 
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also disseminated infections and that different species exhibit varying 
sensitivity patterns to the antifungal agents. To date, there are 14 species of 
Malassezia that have been isolated from human and animal skin.
5,6
 
          Pityriasis versicolor and seborrheic dermatitis are the two most 
common manifestations of  Malassezia,  though  not  alarming  infections,  
known for their chronicity and recurrence and also for raising cosmetic 
concerns in those affected by these conditions.6 
 
This part of our country is known for its hot and humid climate that 
favor the growth of Malassezia yeasts, and hence an understanding of the 
distribution of  these  yeasts  and  the  dominant  species  prevalent,  will  
serve  to  complement the previous  studies  conducted  in India  and 
elsewhere  in determining  the varying trends in distribution that may exist 
in different geographical locations. 
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REVIEW OF LITERATURE 
 
HISTORY 
In 1846, Eichstedt and in 1847, Sluyter identified Malassezia as  the  
causative   agent   of  pityriasis versicolor though they were unable to isolate 
the organism. As the organism closely resembled Microsporum 
audounii, it was named as Microsporum furfur by Robin in 1953.   In 
1874, the French scientist,  Louis Charles Malassez described budding 
‘spores’ in the patients with seborrhoeic dermatitis.7,8 
 Bizzozero named the oval and spherical budding cells as 
Saccharomyces ovalis, and Saccharomyces sphaericus respectively.  In 
1889, in honour  of  Malassez, Baillon used  the  term  Malassezia   
furfur.
9
   
In 1904, Sabouraud  described the genus Pityrosporum which had 
t h e  budding yeast cells without hyphal elements.  In 1913, Chalmers and 
Castellani  isolated the oval lipophilic budding cells from normal skin and 
patients with seborrhoeic dermatitis and gave the name Pityrosporum 
ovale.
9
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Previously, the mycelial form of this fungi was called Malassezia and 
the yeast form was called Pityropsorum orbiculare (round cells with 
budding from narrow neck) or Pityrosporum  ovale (oval yeast cells with 
budding from wide neck). In 1969, Sternberg and Keddie by using the 
fluorescent antibody technique identified antigenic components of 
Malassezia furfur and Pityrosporum orbiculare and found that both of them 
had similar features. In 1984, Yarrow and Ahearn stated that Malassezia 
gained priority over Pityrosporum and was accepted as the generic name for 
the fungus. The lipophilic nature of the genus Malassezia was discovered in 
1939 by Rhoda  Benham.  Von  Abbe  in  1964  described  the  Dixon  
medium  for  the isolation of Malassezia yeasts which was subsequently 
modified for better yield.  On the basis of the distinct cell surface 
antigens, Cunningham and colleagues  in 1990 defined the   serovars A, 
B and C. These serovars are now identified as M. sympodialis, M. 
globosa and M. restricta, respectively. In 1996, following taxonomic 
revision of the genus, four new species, M. globosa, M. obtusa, M. restricta 
and M. slooffiae were included.4,6,9
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TAXONOMY            
 Phylum  Basidiomycota 
 Order     Malasseziales   
 Class      Blastomycetes 
 Family   Cryptococcaceae   
 Genus   Malassezia
3
 
In 1889,  Baillon first identified Malassezia furfur.   It was called by 
various names such as Microsporum   furfur, Malassezia tropica, 
Pityrosporum   orbiculare,  Malassezia macfadyeni,  Microsporum   furfur,  
Sporotrichum   furfur,  Oidium furfur .
3
 
Based  on morphology,  physiology,  cellular characteristics,  
temperature  requirements,  biochemical  reactions, dependence  on 
long  chain  fatty  acids,  guanine  and  cytosine  content  of  cellular  
DNA  and ribosomal RNA sequences, the genus Malassezia has been found 
to have fourteen species.
10
 
  In the year  1925, Dodge identified M.pachydermatis. In 1990, 
Simmons and Gueho isolated M. sympodialis. Midgley, Gueho and Guillot, 
in the year 1996, reported four species namely M. globosa, M.restricta, M. 
slooffiae  and M. obtusa. In 2002, M. dermatis  was identified by Sugita, 
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Takashima, Nishikawa and Shinoda. They also identified M. japonica and 
M.yamatoensis in the year 2003 and 2004 respectively. Hirai, Kano, 
Makimura, Yamaguchi, Hasegawa reported M.nana in 2004. In 2007, 
Cabanes and Boekhout identified M. caprae and M. equi. Recently in 2011, 
F. J. Cabanes reported M. cuniculi.11,12,13 
ECOLOGY 
Malassezia usually inhabit the skin of only warm-blooded animals.  
Malassezia  species require lipids for growth and survival and they are often 
mesophilic. 12   Canine ear infections are caused by M.   pachydermatis 
.Many lipophilic species of Malassezia  have been isolated from pigs, 
monkeys, rhinoceros, bears and birds.
14
 
Crespo  Erchiga  et  al  concluded that M. sympodialis was the most 
common species isolated from normal human skin, especially the 
trunk.
15
Midgley proposed that M. globosa had a higher incidence.16 
The lipophilic yeast abounds in the skin of people from tropical and 
subtropical climates. Individual species have specific host preferences. M. 
sympodialis is the most common species that occur in humans as normal 
flora or at sometimes association with systemic disease. M. furfur, M. 
globosa and M. restricta also infect humans and produce diseases. M. furfur 
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is seldom found as normal flora or in disease states. M. globosa and M. 
restricta are mainly pathogenic, associated with pityriasis versicolor, 
pityriasis capitis or seborrhoeic dermatitis. In humans, the peak age for 
normal carriage or disease by Malassezia is in the early twenties, when the 
sebaceous gland activity is maximum. Colonization or disease by Malassezia 
is rare at the extremes of ages. M. pachydermatis was first isolated from  
rhinoceros. It is mainly found in domestic animals, like dogs, causing otitis 
externa, but occasionally can infect humans.M. slooffiae was demonstrated 
as normal flora on the trunk. This species is also pathogenic in pigs.15          
          The  distribution of Malassezia as normal flora is related to density of 
sebaceous gland, and thus the scalp, face, central chest and back bear the 
highest number of fungi. Other sites, like the hair follicles and the external 
ear, are also the sites of colonization. The hair shaft, nail and mucosae are 
not affected. In an epidemiological study conducted by Rao et al, 97% of the 
normal adult population showed scalp carriage and 92% showed trunk 
carriage for Malassezia.. However, in various studies, hospitalized infants 
have shown a positive skin culture for M. furfur, the incidence varying from 
37% to 84%. Many healthy infants develop a cutaneous flora comprising 
Malassezia species within the first 6 months of life.15,17 
9 
 
PITYRIASIS VERSICOLOR: 
SYNONYMS 
Pityriasis versicolor (PV) is also referred to as Tinea versicolor,  
Chromophytosis, , Dermatomycosis furfuracea, Tinea flavea and  Liver 
spots.
3 
INTRODUCTION 
        The term “Pityriasis versicolor’ is derived from the Greek word 
‘ptyra’ which means abnormal proliferation and the latin word ‘ versicolor’ 
that means  many colours.
3
 
PV is  a mild ,common,  benign superficial fungal infection of stratum 
corneum which is characterized by discrete or confluent, hypopigmented or 
hyperpigmented brawny scaly macules or patches present over the seborrheic 
areas caused by genus Malassezia. It was earlier called as tinea which is a 
misnomer and reserved for dermatophytic infections.
1,16
 
In  Sri Lanka, PV was considered to be a marker of beauty and local ly 
cal led as ‘Gomora’meaning ‘tears of liquid gold’.
16
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EPIDEMIOLOGY 
Age 
PV is more common in adolescents and young adults due to the 
increased sebum production. The amount of yeast that colonizes the stratum 
corneum is proportional to variation in sebum secretion which is in turn age-
dependent. The percentage of yeast that colonizes the skin in the age group 
between 0-15yrs is 5 -15% and in the age group between 11- 20yrs is 56 – 
90%. It is uncommon in older age group because sebaceous glands become 
nonfunctional with old age.3 
Race 
  The incidence of PV is same in all races and it is more common in 
dark skinned individuals.15 
Sex   
Males and females are equally affected. There is no sexual 
preponderance. 15 
Seasonal Variation  
 In tropical countries, due to the  increased temperature and humidity, 
PV is more common during spring and summer.15 Infection is likely to be 
extensive and persistent with an incidence of about 35 – 40% in temperate 
climates. It is less prevalent in colder climate with an incidence as low as 1 – 
4 %.18 
11 
 
Genetic Factors 
It has been postulated that  in pityriasis versicolor  there is a genetically 
determined host susceptible factor, since a positive family history was present 
among blood relations. Conjugal cases can occur ( infection does not arise 
from patient’s own autologous flora rather than by transmission from other 
individuals).3,18 
Predisposing Factors                      
Many systemic conditions favour the development of pityriasis 
versicolor. Some of them are 
1. Cushing syndrome 
2. Pregnancy 
3. Oral contraceptive pill 
4. Diabetes mellites 
5. Tuberculosis 
6. Organ transplant patients  
7. AIDS 
8. Immunosuppressive drugs16 
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Other environmental conditions conditions such as hot climate, high 
humidity, poor personal hygiene and overcrowding also plays a role. 19 Other 
factors like winter season, UV irradiation, airborne irritants and hair 
cosmetics are known to aggravate the condition.6 
Malassezia is usually universal normal flora of the body but under 
certain special situations it overgrows and readily transforms to mycelial 
forms which is slightly more pathogenic.16 
PATHOGENESIS 
Malassezia species is universally present as normal flora of the skin. 
Under certain special conditions, it becomes pathogenic to the human skin 
and produces the disease. Weis et al, by electron microscopic studies 
showed that there is a change in the saprophytic yeast form to filamentous 
mycelial form which determines the pathogenesis of  Malassezia  infections. 
The endogenous or exogenous corticosteroids may lead to the development 
of PV due to reduction  in the turnover  of squamous cells. Malassezia are 
dependent on exogenous lipids, especially 12 to 14 carbon fatty acids for 
their growth.  Human and animal skin rich in free fatty acids, serve as 
media for their growth and survival. In human beings, Malassezial 
antigens interact with neutrophils and monocytes resulting in stimulation of 
IL-8 and IL-1α and IL-8 respectively. 4 Metabolism  of skin surface  lipids 
by lipoxygenase enzymes of Malassezia, yields fatty acids that are toxic to 
the melanocytes.20
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Many theories have been postulated to explain the pigment alterations 
associated with PV: 
1. Studies by Nazzaro – Porro in 1993 stated that Malassezia  
metabolises oleic and vaccenic acids and produces lipid fractions 
like C9  to C11 dicarboxylic  acids.  Azelaic  acid, a dicarboxylic 
acid produced as a metabolite  competitively inhibits tyrosinase in 
the melanin synthesis pathway.20 
2. There is inhibition of the mitochondrial  enzymes that in turn leads to 
degeneration a n d  vacuolation  of the melanocytes leading to smaller 
and fewer melanosomes thus producing hypopigmentation.
21
 
3. Mayer and coworkers did experiments on the metabolism and 
nutritional requirements  of Malassezia species in 1998 and stated 
that M. furfur has the ability to assimilate L- tryptophan as a nitrogen 
source leading to the colour change of the affected skin in PV. The 
presence of abnormal structure of stage 1 melanosomes which are not 
transferred to epidermal keratinocytes is responsible for 
hypopigmentation in PV cases.21 
4.  In 2000, Raabe et al studied the pigmentogenesis of   M. furfur and 
stated that the  indole  pigment , pityriacitrin   produced exclusively   
14 
 
by   M.   furfur   acts   as   a   UV   filter,  thereby preventing   normal 
tanning.
11
 
 5. Weis et al  confirmed  the  penetration  of  Malassezia  into  the  
keratinocytes, causing degradation of the keratin into an amorphous 
lipid–like substance, that acts as a potential ultraviolet light blocker 
which results in hypopigmentation.
10
  
6. There is an increased space between melanocytes and keratinocytes.8 
7. Hyperpigmentation in chromic type of PV is said to be 
multifactorial, namely presence of large number of the causative 
fungi, increased thickness  of  the  keratin  layer,  increased  turnover  
rate  of  cells  in  the stratum corneum, increased perivascular 
infiltration of lymphocytes and increased inflammatory responses that 
stimulate the melanocytes. Hyperpigmented  lesions  have  been  
found  to  contain  more  hyphae  and spores than the hypopigmented 
lesions.
21
 
8. In studies by Sugita et al, hyperpigmented  lesions were found to 
show an increased turnover rate of stratum corneum, i.e, 8 days 
compared  to 15 days for normal areas.  T h e y  also observed the 
presence  of singly distributed, large melanosomes in contrast to 
multiple – packaged, smaller melanosomes in normal areas.
12
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METABOLITES OF Malassezia furfur2 
Azelaic acid: a dicarboxylic acid that inhibits tyrosinase.  
Malassezin: it is an aryl hydrocarbon receptor agonist that induces apoptosis 
in melanocytes.  
Pityriacitrin: it is a yellow compound that helps in absorbtion of  UV light.  
Pityrialactone: an indole alkaloid (tryptophan derivative) that fluoresces 
under 366 nm UV light.  
Pityriarubins: a red indole alkaloids that inhibit the neutrophil respiratory 
burst in vitro in a dose dependent manner and inhibit 5-lipoxygenase activity.2 
 
      Malassezia plays a definite role 
              
             Possible role of malassezia 
• Pityriasis versicolor  
• Systemic intravenous catheter 
induced fungemia with or 
without embolism   
• Endocarditis   
• Interstitial pneumonia   
• Peritonitis in patients 
undergoing chronic 
• Dandruff   
• Folliculitis   
• Neonatal cephalic pustulosis  
• Confluent and reticulate 
papillomatosis   
• Atopic dermatitis   
• Seborrheic dermatitis   
• Guttate psoriasis  
16 
 
 
CLINICAL FEATURES: 
The clinical lesions of pityriasis versicolor have well defined borders 
with a clear cut edge and occurs in various shapes. The colour of the lesion 
may vary according to the interaction between the host and Malassezia. 
Clinical type and distribution depends on the skin colour of the patient, extent 
of colonization and degree of exposure of colonized areas to sunlight. 
Individuals may have either hypopigmented (Achromic pityriasis versicolor) 
or hyperpigmented lesions (Chromic versicolor) or both together.1 
   The morphology of the lesion may be macules, patches, follicular,  
 perifollicular or papular. Atrophic form of PV has been reported by Kyle et al 
in 2014. They stated that Malassezia produce diffusible products that activate 
tissue histiocytes and result in dermal elastolysis.1,22 
ambulatory peritoneal dialysis • Blepharitis   
• Balanitis   
• Onychomycosis   
• Lacrimal canaliculitis and 
dacryolith  Sinusitis   
• Nipple discharge   
• Otitis externa12 
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 In children, paranasal distribution of PV is characteristic. The primary 
lesion is a sharply demarcated macule with characteristic ﬁne, branny scaling 
 The macules may coalesce to form large confluent areas  with scattered  
oval patches and outlying macules. They are usually asymptomatic but some 
of them may have mild itching or burning  sensation. Patients mostly come to 
the hospital due to the cosmetic concern and fear of social stigma attached to 
hypopigmented lesions.1 
 
DISTRIBUTION OF THE LESION 
    As the fungus is lipophilic, it occurs mostly on the seborrheic areas 
such as upper chest, neck, face, back, upper arm and abdomen. In the tropics, 
facial, palmar and scalp lesions are common. Sometimes pityriasis versicolor 
can occur in entirely different distribution affecting the flexural regions such 
as axillae, groin, thigh and genitalia when it is known as inverse pityriasis 
versicolor. Sometimes pityriasis rosea like lesions can occur. 2,15 
COUP D’ONGLE SIGN OF BESNIER 
The one significant sign associated with the diagnosis of tinea 
versicolor is that of the coup d' ongle of Besnier (1831-1909), later named by 
18 
 
Balzer (1849-1929) as le signe du copeau (shaving, as of wood) or in 
German “Hobelspanphänomen”. It is also called as “scratch sign”.16 
The description is as follows: 
"Sometimes the spots are smooth, sometimes powdery and manifestly 
branny, but this distinguishing mark is not evident in all of the stages of 
evolution of the parasite, and its diagnostic value is secondary; what is 
constant is the alteration in the consistency of the superficial horny layer of 
the epidermis, which, infiltrated with the Microsporon (Malassezia) is easily 
crumpled and detached either by the stroke of the curette, or more practically 
by the scrape of the fingernail. A scratch of the nail made a little vigorously, 
even without reaching the summit of the papillae and without causing the 
least degree of bleeding, easily produces the desquamative lamella which is 
almost pathognomic”.16 
ZIRELI’S SIGN 
Clinical manifestations of pityriasis versicolor are characterized by 
multiple macular lesions, perifollicular at first, with light scaling. Stretching 
of the affected skin may help in better visualization of the scaling of lesions. 
This is known as Zireli’s sign. 23 
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UNUSUAL PRESENTATIONS OF MALASSEZIA: 
PITYROSPORUM  FOLLICULITIS( RAUSCH AND JACABS 1984)1 
It is a delayed type of hypersensitivity to Malassezia species.  
Overgrowth of the yeast causes blockage of follicular ostia. It is proposed that 
hydrolysis of triglycerides, fatty acid synthesis and activation of the alternate 
complement pathway by the fungus induce inflammation, resulting in 
folliculitis. Pityriosporum folliculitis (PF) manifests as itchy perifollicular 
erythematous papules or pustules over back, chest and extremities and mimics 
steroid induced acne. Presence of itching helps to differentiate these two 
conditions. Most often PF is associated with SD. Histopathologically, there is 
a perifollicular mononuclear cell infiltrate around the infundibulum. In skin 
lesions, there is an increased number of T helper cells and Langerhans cells. 
Malassezia yeasts are seen, but mycelial forms are usually absent in contrast 
to PV.  Topically, selenium sulphide wash may be useful. Systemic treatment 
includes tab. ketoconazole 200mg daily for four weeks or tab. fluconazole 
150 mg once weekly for 2-4 weeks or itraconazole 200mg once a day for 2 
weeks. 1 
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CONFLUENT RETICULATE PAPILLOMATOSIS 1,24 
This rare disease of keratinization manifests as grey brown, pigmented 
confluent papules in the interscapular area, neck, abdomen and under the 
breast. Neighboring papules become conﬂuent in the centre of the affected 
areas forming an irregular network. It was initially believed to be a 
genodermatosis but studies have demonstrated Malassezia furfur in the scales. 
Natarajan et al identified a novel Actinomycete, “Dietzia papillomatosis” as 
an etiological agent in CRP, but this ﬁnding is yet to be confirmed. Clinical 
response to antifungal agents  is variable Topical vitamin D analogues and 
retinoids can be tried. Oral azithromycin and minocycline have also been 
used.1Electron microscopic features includes a marked alteration of the 
cornified cell structure resembling snake coil like or triangle like stacks and 
increase in the number of lamellar granules.1  
SEBORRHOEIC DERMATITIS  
‘Sebum’ means  ‘grease’ and ‘rhoea’ means ‘flow’. Seborrhoeic 
dermatitis is a chronic papulosquamous disorder seen predominantly in 
young   adults, that  manifests as erythematous, pruritic scaly lesions in the 
scalp and face, particularly,  forehead,  external  auditory  canal,  nasolabial 
folds, retroauricular areas, eyebrows and moustache and also the presternal 
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area. The incidence is about  3 – 5%   of   the   general   population. 
Seborrhoeic dermatitis is the earliest clinical marker of HIV. In Acquired 
Immuno Deficiency Syndrome (AIDS) patients with low CD4 counts, 
seborrheic dermatitis is often severe and difficult to treat. 
Therapeutic studies have  confirmed the causative role of Malassezia 
in seborrheic dermatitis due to the response to ketoconazole .   
  The patients with SD have high skin surface levels of squalenes  and 
free fatty acids (FFA).   Malassezia species possess lipase activity, that 
converts triglycerides to free fatty acids.  The FFA and the reactive oxygen 
species (ROS) which are formed have the antibacterial activity that alters 
the normal skin flora. This disturbance in flora, lipase activity and ROS may 
be linked to the pathogenesis of SD.
9,13
 
Malassezia species produces increased amount o f  aryl hydrocarbon 
receptor(AhR)  ligands and   an interplay of the AhR and EGFR (Epidermal 
Growth Factor Receptor) has also been proposed to play an important role in 
SD.
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DANDRUFF (PITYRIASIS CAPITIS OR PITYRIASIS SIMPLEX) 
It is a subclinical, inflammatory scalp disorder, episodic, recurrent or 
constant, that results in disruption of cohesion between corneocytes, visible as 
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scales. The disorder is most prevalent and severe among adolescents and 
young adults, and rare among children and the elderly. Environmental factors 
like winter season, UV irradiation, airborne irritants and hair cosmetics are 
known to aggravate the condition. Malassez (1874) had isolated the yeast 
forms of the species from dandruff scales. It has been hypothesized that a 
critical quantity of the yeasts are required for the clinical manifestation of 
dandruff and when it exceeds this, features of seborrheic dermatitis are seen. 
The oval yeast form of M. restricta has been isolated from dandruff scales. 
Toxin production and lipase activities of the yeast inducing a proinflammatory 
state and stimulating host immune response may be operative in the 
pathogenesis. Environmental factors have some additive effect on the 
pathogenicity of the fungus. There is a definite response to topical antifungals 
when Malassezia is associated with dandruff.26 
FUNGEMIA  
It is commonly seen in premature infants who are on total parenteral 
nutrition with intravenous lipid supplementation. They develop extensive 
vasculitis of small pulmonary arteries and also pneumonia. Fungemia can also 
result from catheterization by the proliferation of fungus from patient’s skin 
and then dissemination. Fungemia occurs most commonly in 
immunocompromised host.26 
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DACRYOCYSTITIS 
Malassezia species colonize the lacrimal sac and produce swelling of 
the lacrimal sac and obstruction leading to dacrolith formation and finally 
inflammation. 24 
PSORIASIS 
Malassezia species produce an immunological reaction which plays a 
minor role in the pathogenesis of psoriasis.24 
ATOPIC DERMATITIS 
Malassezia furfur was isolated from skin lesions of atopic dermatitis. In 
such individuals, atopic eczema can be induced by Malassezia yeast. Also, 
IgE antibodies were found against Malassezia furfur in patients with atopic 
dermatitis.24 
TRANSIENT ACANTHOLYTIC DERMATOSIS has been found to be 
associated with Malassezia.24 
INFANTILE CEPHALIC PUSTULOSIS IN NEW BORN 
Earlier, considered as neonatal acne, is characterized by non-follicular 
pustular eruption involving the face, neck and scalp. The incidence in 
hospitalized neonates is 3% .The diagnostic criteria include age of onset less 
than 1 month, cephalic location, smear positivity for Malassezia, elimination 
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of other causes of neonatal pustulosis, and response to topical ketoconazole. 
M. furfur is the most commonly found species. In the severe form, it is 
associated with M.sympodialis.24 
Miscellaneous 
The fungus has further been isolated from the nasal passages and 
nasopharynx in patients with maxillary sinusitis and osteitis. It has been found 
to produce onychomycosis and endocarditis. 24 
HIV INFECTION AND MALASSEZIA 
The growth of Malassezia is known to be enhanced in 
immunocompromised conditions. The skin flora remains quantitatively 
normal in HIV infected patients. In an Indian study by Kaviarasan et al, the 
authors found the overall incidence of Malassezia infection among HIV 
infected patients to be 13.5%; they observed the incidence of PV, Malassezia 
folliculitis and SD to be 40%, 16% and 56% respectively. Among their 
patients, 9 of them had a clinical diagnosis of AIDS. 27 A higher incidence and 
severity of SD has been reported in AIDS patients (30-55% vs 1-3%) in the 
normal population. The incidence of SD in these patients can be correlated 
with CD4+ T cell counts; with > 200 cells it is 15% and with < 200 cells, it 
becomes 58%. Thus, it appears that immunosuppression in HIV infection 
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enhances Malassezia growth.28 In the series of HIV infected patients reported 
by Kaviarasan et al, extensive PV and SD with an aggressive course were 
observed in advanced stages of immunosuppression, and the authors have 
proposed that the presence of such features can be used as a clinical marker of 
AIDS in resource poor countries. It has been proposed that aggravation of SD 
in HIV infected patients is not directly related to Malassezia growth. In 
disease states, the level of toxic products of Malassezia rises, increasing the 
prevalence and severity of SD. Moreover, the HIV infected state increases the 
level of interferons and tumor necrosis factor-α, which are known to alter the 
lipid metabolism, increasing serum triglyceride and cholesterol levels. This 
increases the patient’s sensitivity to inflammatory mediators released by 
Malassezia. Though the genus Malassezia has been associated with many 
cutaneous and systemic disorders, its exact role in the causation of most of 
these conditions is yet to be elucidated.29 
DIFFERENTIAL DIAGNOSIS FOR ACHROMIC PITYRIASIS 
VERSICOLOR 
Seborrheic dermatitis is a chronic, recurrent, relapsing dermatitis with 
a distinctive morphology and it is considered to be an altered cell mediated 
response to Malassezia species.1,4. 
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Pityriasis alba, an endogenous eczema occurring in children which is 
characterized by hypopigmented patch over the face with indistinct borders. 
P.alba is associated with atopy and nutritional deficiency.2  
  Pityriasis rosea is characterized by erythematous patch which is oval 
or circular in shape with collarette of scales and exihibits a typical Christmas 
tree pattern.2 
Indeterminate Hansen manifests as vaguely defined  hypopigmented 
patch with minimal scaling without any loss of sensation over the face and 
gluteal region. It may either resolve spontaneously or progress to borderline 
Hansen disease.2 
Neavus anaemicus is also known as pharmacological naevus. On 
diascopy, it merges with the normal skin. On Wood’s lamp examination the 
lesion does not accentuate.2 
Naevus achromicus is present since birth with serrated border and the 
lesions are nonscaly. On diascopy, the lesion will not merge with the 
surrounding skin.2 
Early vitiligo is a depigmenting autoimmune disorder due to loss of 
epidermal melanocytes. The lesions of vitiligo are nonscaly, milky white with 
a well defined border.2 
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Macular syphilid  is characterized by oval or round, faint pink lesions 
which occurs over nape of the neck, sides of the trunk and flexor aspects of 
the extremities. VDRL and TPHA will be positive.2 
Ash leaf macules of tuberous sclerosis is present since birth or early 
infancy.The lesions are polygonal or ash leaf in shape which may be 1-100 in 
number. On Wood’s lamp examination, lesions will get accentuated.2 
Post kala azar dermal leishmaniasis is characterized by pinpoint 
macules and patches which is hypopigmented and later the lesions become 
raised. This condition mainly occurs after treatment of visceral leishmaniasis.3 
Lichen sclerosus et atrophicus is characterized by porcelain white 
macules or plaques with induration and the patient will have itching.2 
Resolving psoriasis- Psoriatic patients being treated with topical 
steroids or PUVA therapy have post inflammatory hypopigmentation.2 
Resolving miliaria rubra  on exfoliation may present with white 
coloured scaly macules occurring around eccrine orifices.3 
DIFFERENTIAL DIAGNOSIS FOR CHROMIC PITYRIASIS 
VERSICOLOR 
Erythrasma is a bacterial infection caused by Corynebacterium 
minutissimum mainly affecting the flexural areas. It manifests as 
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hyperpigmented, well defined maculopapular lesions with satellite lesions 
nearby. On Wood’s lamp it produces characteristic coral red fluorescence. In 
axilla, vault involvement is characteristic of erythrasma in contrast to PV, 
where the vault is spared.1,3 
Melasma presents as non scaly, blotchy, macular pigmentation with a 
reticulated appearance over the face. Most commonly seen in females.1 
  Lentigenes is characterized by  hyperpigmented macular lesion which 
is non scaly.1 
Junctional naevus is an acquired melanocytic naevus that presents as 
uniformly pigmented a macule or patch which is non scaly.2 
Café au lait macules appear at birth or soon after birth and tend to 
disappear with age and manifests as nonscaly, brown coloured macules with 
irregular borders.1 
Acanthosis nigricans is commonly seen in flexures and presents as 
verrucous lesion but they are soft to touch.2 
Vagabonds disease is seen in pediculosis corporis.1  
DIAGNOSIS  OF  PITYRIASIS VERSICOLOR 
The diagnosis of  pityriasis versicolor is essentially clinical. When 
there  is  a  cl inical  suspicion ,  s imple  invest igat ion  like  potassium 
hydroxide mount can be used .
30
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Culture is mainly done for  academic and epidemiological  purposes 
and for the confirmation of unusual manifestations of PV. 
Pityriasis vesicolor can be detected by the characteristic  fluorescence  on 
Wood’s lamp examination.
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WOOD’S LAMP EXAMINATION 
The skin lesions of  pityriasis versicolor gives a yellowish orange or 
golden yellow fluorescence w h i c h  i s  due to t he  p r e senc e  o f  
coproporphyrin. The exact extent of skin involvement and subclinical 
infection may also be determined.
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SPECIMEN COLLECTION: 
The nature of the specimen collection for Malassezia depends on 
the type of the disease involvement.  In case of pityriasis versicolor, 
skin scrapings are sufficient. Rarely punch biopsy may be done.  
Other specimens of Malassezia infections includes nail clippings 
for onychomycosis, peritoneal fluid for peritonitis, respiratory secretions for 
pneumonia , catheter tip and venous blood in case of fungemia. 32 
Collection of skin scrapings 
The skin lesion of the patient is cleaned with 70% isopropyl alcohol in 
order to remove the surface  contaminants. The  area  is  allowed  to  dry and 
using the blunt end of a no. 15 flame– sterilized scalpel blade or the edge of a 
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glass slide, the skin scrapings are co l lec ted  on  an   alcohol cleansed, 
flame-sterilized glass slide, from the active edges of the lesion. 
 The specimens from scalp includes the hair stubs, scales and the 
contents of the plugged follicles.
32 
Scotch tape method 
This method is more useful when the scales are minimal but culture 
cannot be done by this method. Scales can be removed using clear adhesive 
tape also called as scotch tape or vinyl adhesive tape. The tape must be clear 
and should be pressed firmly over the affected area of the skin. It is then 
removed and kept over a glass slide.32 
DIRECT MICROSCOPY 
Potassium hydroxide (KOH) mount 
The  scales  obtained  by a n y  o f  t h e  a b o v e  m e t h o d s  from  
affected area  are examined  under light microscope with 10% KOH. KOH 
digests  the keratin and cellular debris and helps in visualization of fungal 
elements.
30 
Modifications of KOH mount30 
 
 Dimethyl  sulfoxide  (DMSO)  may  be  added  to  the  preparation,  
which allows better visualization by acting as a clearing agent. 
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 Methylene blue may be added to delineate fungal elements. 
 Albert’s stain stains the yeast cells and hyphae purple, delineating  
them from the background of keratinocytes. 
 Parker Quink’s blue or black ink can be used with KOH to 
enhance the contrast 
CHICAGO SKY BLUE INK 6B33 
 Direct microscopic examination of samples from the affected area using 
potassium hydroxide (KOH) wet mounts is the most widely-used laboratory 
method. Although rapid, the KOH wet mount lacks a color contrast and 
requires considerable skill to interpret. In busy clinics, it is useful to have a 
rapid, reliable, and easy to interpret diagnostic method.                                 
                 Chicago sky blue (CSB) stain is a new contrast stain that has shown 
as a promising rapid and reliable diagnostic method for dermatomysoses and 
pityriasis versicolor. It contains 1% CSB 6B and is used together with KOH as 
the clearing agent. Use of Chicago sky blue stain along the KOH wet mount 
helps to detect all cases of pityriasis versicolor at the 30-minute examination 
with no additional cases detected on Day 2. This suggests a 30-minute 
examination is adequate for detecting M. furfur. Fungal elements stain blue.33 
Calcoflour white stain(CFW) 
CFW  is a water-soluble,  non-toxic,  colourless  fluorescent  whitener  
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and textile dye that selectively binds to cellulose and chitin of the fungal 
cell wall. When viewed under fluorescent microscope, it fluoresces light 
blue on exposure to UV light (340 –   365 nm).
34 
 CFW stain is superior to conventional  KOH mount in that it 
provides a better differentiation of hyphal elements and collagen fibres. 
Appearance in direct microscopy 
Under direct microscopic examination of 10% KOH, modified KOH 
or CFW preparation, a l l  t h e  Malassezia species a r e  s e e n  a s  clusters 
of round or oval 2 – 7 µ yeast  cells  and  short  (  about  20  –  25  µ), 
straight or angulated,  stout,  aseptate, hyaline hyphal elements along with 
blastospores showing the characteristic ‘banana and grapes’ or ‘spaghetti 
and meat ball’ appearance or ‘foot print shaped’appearance.1,5 
Punch biopsy 
Punch biopsy of skin can be done from the affected area and stained 
with haematoxylin and eosin. Special stains such as  Giemsa, Periodic acid 
Schiff stain and  Gomorri’s methanamine silver help to confirm the 
diagnosis.
35
  
Histopathology reveals the presence of  yeast cells and hyphal elements 
in the stratum corneum. There is thickening of stratum corneum and patchy 
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perivascular lymphocytic inflammatory infilterate in the dermis. 
Hyperkeratosis, increased density of the fungus and increased dermal 
inflammatory infilterate are characteristically seen in  the hyperpigmented 
type of PV.
35,36
 
CULTURE: 
All the species of Malassezia are lipophilic and require lipid 
supplemented media except M.pachydermatis.
 
But culture is not mandatory 
in the diagnosis of Malassezia infections.34 
Growth requirements 
All Malassezia species except M. pachydermatis require fatty acids for 
their growth in vitro particularly of saturated or unsaturated fatty acids 
containing C12 to C24 series. Any media that contains  glycine,  glucose,  
mineral  oils, glycerol monostearate or Tween 80 supports the conversion of 
yeast to mycelial form. Glycine has a unique positive effect on the growth 
of M. furfur.
34
 
        The ideal temperature for the growth of all Malassezia species is 30   -   
35˚C.Temperature  above this range inhibits most of the species.   
Preservation of the culture is done  by  freezing  at  -80˚C,  as Malassezia 
cannot withstand temperatures of 4 - 8˚C.
34
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CULTURE MEDIA 1,3,4,34 
The following media are used for  the isolation of Malassezia species: 
1. Sabouraud Dextrose Agar with actidione and  overlay of olive oil 
2. Modified Dixon’s agar 
          This agar gives substantial  growth of the fungi with different 
morphological  patterns for identification. It contains 3.6% malt extract, 0.6% 
peptone,1% Tween40, 2% desiccated ox bile, 0.2% glycerol, 0.2% oleic acid. 
3. Leeming and Notman medium  
         It has whole fat cow’s milk,  and produces high recovery rate and 
longer shelf life. 
4. GYP-S  agar 
           It gives quicker growth and quantitation of colonies.This media 
consists of peptone, glucose, yeast  extract, olive  oil, Tween  80,glycerol 
monostearate 
5.  A  minimal  medium containing a lipid  source  and  L-  tryptophan is 
used specifically for M.furfur which produces a diffusible brown 
pigmentation.
 
Malassezia species are part of normal commensal flora of human skin. 
So it is necessary that the culture media must be supplemented with 
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cycloheximide and chloramphenicol.3 
COLONY MORPHOLOGY ON MODIFIED DIXON’S AGAR 2,32 
 
The   morphological   features   of   the   colonies   of   commonly   
isolated Malassezia  species on modified Dixon’s agar are as follows:  
Malassezia furfur : 
M. furfur generates cream coloured, thick, convex, umbonate, 4 – 5 
mm colonies with a smooth to rough surface. 
Malassezia pachydermatis: 
 
M. pachydermatis  forms  cream  coloured,  thick, convex  colonies  
with a matte surface and brittle texture, making it difficult to emulsify.  
Malassezia sympodialis: 
 
M. sympodialis forms cream to buff coloured, flat, easily emulsifiable 
colonies with a slight central elevation and a smooth shiny surface. 
Malassezia globosa: 
 
M. globosa produces 4 mm cream to buff colonies with a rough and 
deeply folded surface and a brittle texture and hence are difficult to emulsify. 
Malassezia obtusa: 
 
M. obtusa is a slow growing species and forms small colonies with a 
sticky texture.37 
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Malassezia restricta: 
 
M. restricta is slow growing and forms irregular, small, 2 mm sized, 
cream coloured colonies with a hard texture.  
Malassezia slooffiae: 
 
M. slooffiae forms 3 mm colonies, with finely folded margins and a 
brittle texture.  
Ideally a l l  the  inoculated culture media must be incubated for a 
period of 7 – 10 days at a temperature range  of 30 - 35˚C (preferably at 
32˚C), and examined dai ly for growth.
3
 
BIOCHEMICAL CHARACTERIZATION: 
Conventional   assimilation   and   fermentation   tests   employed   in   
the speciation of other yeasts cannot be used for these non–fermentative,  
lipophilic species.
3  The various tests used to identify Malassezia species are 
as follows: 
Urease test: 
All species of Malassezia produce urease enzyme that hydrolyzes urea. 
This test can be done by using Christensen’s urea agar or broth medium. 
Positive test is indicated by the colour of the medium turning into pink.
4
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Catalase test: 
Malassezia species  is catalase positive. 20 – 30% hydrogen peroxide 
is used for this test .  On adding the agent M. restricta is the only species 
that is catalase negative.
4 
Esculin hydrolysis test: 
Malassezia species contains beta glucosidase enzyme present which 
has the capacity of hydrolyzing esculin. Esculin is converted in to esculetin 
that reacts with iron in the medium producing black colour of the medium. 
Positive test is seen in M.   sympodialis, M.cuniculi, M.caprae and  M.obtusa  
Weakly positive or absent in  M. furfur  
Variable - M. pachydermatis.
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Growth at 42˚C: 
          The capability of growth at a temperature of 42˚C is determined. M. 
sympodialis, M. pachydermatis, M.japonica, M.slooffiae, M. cuniculi, M. 
furfur and  M.dermatis shows positive growth.3,32 
Tween assimilation test:     
Tween compounds are polymers of ethylene oxide linked to sorbitan 
and a lipophilic group. They are water soluble and  nonionic  surfactants. 
Each Malassezia species has the ability to utilize different Tween 
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compounds,  (i.e,  10%  Tween  20,  0.5%  Tween  40,  0.5%  Tween  60  and  
0.1% Tween 80) which acts as a source of lipid:
3,32
 
Tween 20  - Polyoxyethylene (20) sorbitan monolaureate  
Tween 40  - Polyoxyethylene (20) sorbitan monopalmitate  
Tween 60  - Polyoxyethylene (20) sorbitan monostearate  
Tween 80  - Polyoxyethylene (20) sorbitan monooleate3,35 
CHARACTERISATION OF MALASSEZIA SPECIES: 
Based  on  the  results  of  the  above  biochemical  tests,  the  14 
species  of Malassezia  can be identified  as follows according  to the 
scheme suggested  Mayser et al and Gueho et al.
10 
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SCHEMATIC REPRESENTATION OF IDENTIFICATION OF MALASSEZIA ISOLATES: 
SKIN SCRAPINGS  
 
 
KOH MOUNT,PARKER QUINK’S STAIN 
 
 
SPAGHETTI AND MEAT BALL APPEARANCE 
 
 
           SDA WITH OLIVE OIL AND  MODIFIED DIXON’S AGAR 
 
 
UREASE POSITIVE 
 
 
SUBCULTURE ON SDA WITH OLIVE OIL 
 
 
NON LIPID DEPENDANT SPECIES LIPID DEPENDANT SPECIES         
 
 
 
Growth absent                                     Growth present  
     
 
M. pachydermatis 
Catalase test 
 
 
                                           Positive     Negative    
   
 
M.restricta 
 
 
 
 
Tween assimilation patterns using Tweens 20, 40, 60, 80 
  
40 
 
 
 
 
 
Assimilates          Assimilates           Assimilates                 No specific 
 
20,40,60,80            40,60,80                  20,40,60                       pattern 
 
 
Beta glucosidase activity 
 
 
Weakly 
 
positive                 Positive                 Negative    Positive            Negative 
 
 
M. furfur              M. sympodialis          M. slooffiae                        gram stain 
 
 
                                                           Cylindrical cells            globose cells                                                                   
 
                                         with broad based budding            narrow based budding 
    
 
 
 
                                                                             M. obtusa                       M.globosa                 
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BIOCHEMICAL CHARACTERIZATION 3,32 
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IMMUNODIAGNOSI 
 Cell mediated immunity response  to  specific  fungal  antigens is 
assessed by lymphocyte blastogenesis.  Solid phase ELISA technique can be 
used to measure antibody  titers  specific  to  Malassezia species.
38  
ANIMAL PATHOGENICITY 
 Experimental studies conducted in common laboratory animals like 
guinea pigs and Swiss white mice have resulted in the development of 
experimental dermatitis showing hyperkeratosis at pilous bulbs and follicular 
ostia.
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MOLECULAR DIAGNOSIS 3 
 Molecular testing methods give exact identification of the Malassezia 
species for diagnostic and epidemiological purposes.  T h i s  h e l p s  in 
rapid screening of large number of isolates in epidemiological surveys. 
Various methods are as follows: 
 Estimation  of the G+C content of chromosomal  DNA    
 25S rRNA sequencing and karyotyping,    
 Restriction   fragment   length   polymorphism   (RFLP)  
 Multilocus enzyme electrophoresis (MLEE)  
 PCR fingerprinting 
 Randomly amplified polymorphic DNA analysis (RAPD)  
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MANAGEMENT OF PITYRIASIS VERSICOLOR 
 As Malassezia species are endogenous to the skin flora, this 
condition is particularly  difficult to eradicate. Our aim is to prevent 
recurrence of infections. In the meantime, there are a number of topical and 
oral antifungal treatments that are effective in alleviating clinical symptoms 
and producing mycological cure.  Relapse may occur. Patient must be 
instructed regarding the pigmentary changes as it may take some time to 
resolve.39 
TOPICAL TREATMENT40 
Various topical antifungal agents used are as follows : 
Topical imidazoles 
2% clotrimazole, 1% miconazole, 1% econazole, 2% fenticonazole, 1% 
oxiconazole, 1% bifonazole. 
Topical triazoles 
1% fluconazole, 2% ketoconazole 
Topical allylamines 
1% terbinafine , 1% naftifine41 
44 
 
Topical benzylamines 
1% butenafine 
Hydroxy piridone  
1% ciclopiroxolamine 42 
Non specific agents 43 
 Topical keratolytics were used in the treatment pityriasis versicolor in  
previous days. They are non specific and they try to remove infected stratum  
corneum either physically or chemically. It includes Whitefield ointment 
(salicylic acid 3%, benzoic acid 6% with 24% coconut  oil in a paraffin 
base),Sulphur with salicylic acid ointment.2.5% selenium sulphide supplied as 
shampoo,1% tolnafate ointment,20% sodium hypochlorite lotion with a 
contact time of 5-7mins.,1% zinc pyrithione as shampoo,2.5%  benzoyl 
peroxide,50:50 propylene glycol in water 
 Creams are ideal for limited involvement while lotions are best suitable 
for extensive area of involvement. Ketoconazole foam is a newer option for 
treatment and may be preferable than shampoo or cream in case of extensive 
involvement, as easier application may lead to increased patient compliance.39 
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 Treatment once or twice daily for 14 days with topical ketoconazole 
cream or foam, and once weekly use of ketoconazole shampoo may be 
effective treatment for PV, with cream or foam showing long-term efficacy.39 
Similarly, topical terbinafine cream could be applied twice daily for 7  
days.Treatment efficacy of topical formulations may be lower in more tropical 
climates.   
 Some of the newer topical immunomodulatory agents such as 
calcineurin  inhibitors  like  tacrolimus  0.1% for adults  and 0.03%  for 
children pimecrolimus 1% are being tried .
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Systemic therapy 43 
Indications: 
• Recurrent lesion  
• Extensive lesion 
• Chronicity 
• Scalp infection 
• Unusual presentations 
Systemic treatment includes 
Tab.Ketaconazole 200mg once daily for 15 days (or) 
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Tab.Itraconazole 200mg once daily for 15 days 44   (or) 
Tab.Fluconazole 50mg daily for 15 days.2 
Pulse therapy 2,43 
 Tab. Ketoconazole 400mg on 2 consecutive days in a week for 2 
weeks( or)Tab. Itraconazole 600mg stat(or)Tab.Fluconazole 400mg single 
dose repeated after a week. 
Prevention of recurrence: 
 Tab. Ketoconazole 200mg once a day for 5 days for 3- 6 months 
                                     or 
 Tab. Itraconazole 200mg once a day for 5 months for 3 – 6 months 6 
along with short contact topical application of selenium sulphide for 10 
minutes on the 1st and 2nd day. 
 Pramiconazole is a relatively new triazole that disrupts ergosterol 
synthesis in fungal cells. It has been shown to be active in vitro against 
dermatophytes, Candida species, and Malassezia species. At concentrations 
<1 µg/mL, pramiconazole activity was twice that of itraconazole  against 
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Candida species, and 10 times greater than ketoconazole against Malassezia 
species.  Recommended dosage is 200 mg pramiconazole daily for 2 days. 
Diarrhea and nausea were the most common adverse effects, with the study 
drug formulation (hydroxypropyl-ß-cyclodextrin) likely contributing to this.46 
Overall, pramiconazole may be a promising treatment for PV however, it 
remains to be determined the clinical efficacy of pramiconazole in relation to 
existing oral antifungals.45 
 Amphotericin B or fluconazole is used in the treatment of fungemia 
and also timely removal of the intravascular catheter and stoppage of 
parenteral lipid infusion is needed.
3  
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AIMS AND OBJECTIVES OF THE STUDY 
 
• To study the epidemiology of pityriasis versicolor. 
• To study the various clinical types. 
• To study the association of pityriasis versicolor with other 
dermatological disorders and systemic diseases 
• To identify the various species of Malassezia   
• To study the clinicomycological correlation. 
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MATERIALS AND METHODS 
 This study was conducted in the mycology section of department of 
dermatology, madras medical college and Rajiv Gandhi Government General 
Hospital Chennai. Hundred patients with pityriasis versicolor who attended 
the mycology OPD between September 2014 and August 2015 were selected 
for the study.  
Inclusion Criteria:  
1. Patients having clinical signs of pityriasis versicolor 
2. KOH positivity for Malassezia 
3. Not taken topical or oral antifungal medication  3 months prior to study 
Exclusion Criteria: 
1. Patients who have taken topical or systemic antifungal treatment within 
3 months prior to the study. 
2.       KOH negativity for fungus. 
Procedure: 
 100 randomly selected patients with clinical diagnosis of pityriasis 
versicolor who have not taken any topical or systemic antifungal treatment in 
the previous three months were selected for the study. 
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 Detailed case history of each patient with reference to age, sex, 
occupation, marital status, seasonal variation, family history, history of 
exposure to sexually transmitted disease in those with high risk behaviour, 
other associated systemic conditions such as diabetes, tuberculosis, endocrine 
diseases, pregnancy, immunosuppressive states (HIV, transplant patients, 
internal malignancy) and malnutrition was taken. History with regard to other 
associated dermatological disorders such as acne, seborrhoeic dermatitis, 
dermatophytosis, candidiasis, acanthosis nigricans etc was taken.  
 Clinical features like site of involvement, percentage of body surface 
area, type of the lesion, other associated systemic and cutaneous disorders 
were noted. Blood haemogram, blood sugar, renal and liver function tests, 
serum cholesterol, blood grouping and typing were done. Blood VDRL for 
syphilis and ELISA for HIV infection were done in patients with extensive 
pityriasis versicolor. 
 Skin scrapings of each patient was examined in 10% KOH for the 
presence of hyaline, short, straight, angulated, aseptate hyphae with 
blastospores .  All the positive specimens were subjected to culture. The 
selected site was cleaned with 70% alcohol and then scraping was done and 
scales were inoculated into modified Sabouraud’s Dextrose Agar medium 
51 
 
with chloramphenicol, actidione with olive oil overlay and kept at 37 degree 
Celsius in an incubator for 48 -72hrs. Macroscopic appearance of the colony 
was noted. Microscopic appearance of the colony in Gram’s stain and lacto 
phenol cotton blue was observed. Tween assimilation test was done for the 
isolation of species.  
Follow Up 
 Patients were started on topical and/ systemic treatment depending on 
the extent of involvement and recurrence. They were advised to come after 
one week with all the investigation reports. 
 
 
 
 
  
 
 
 
OBSERVATION AND 
RESULTS 
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OBSERVATIONS AND RESULTS 
Table 1: Age and gender distribution in the study population(n=100)                                     
 
 Total  no. of  cases Male Patients Female Patients 
Age in 
years Number % Number % Number % 
11-20 22 22 16 16 6 6 
21-30 43 43 27 27 16 16 
31-40 27 27 20 20 7 7 
41-50 4 4 3 3 1 1 
51-60 3 3 3 3 0 0 
61-70 1 1 1 1 0 0 
TOTAL 100 100 70 70 30 30 
 
 Out of the 100 patients with pityriasis versicolor, 43(43%) patients were 
between the age group of 21-30 years, followed by 27 patients 
(27%)belonging to 31-40 years. Out of the 43patients(43%), 27were 
males(27%), 16 were females (16%). The youngest age was a 13 year old 
male and the oldest was a 65 year old male. 
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Fig 1.Age and gender distribution in the study population(n=100) 
 
 
 
 
 
 
 
 
 
 
Table 2:Gender distribution of Pityriasis versicolor  
in the study population (n = 100) 
Sex No.of patients % 
Male 70 70 
Female 30 30 
Total 100 100 
 
 Out of the hundred patients, 70were males(70%)  and 
remaining 30 were females (30%). 
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Figure  2:Gender distribution in the study population (n = 100) 
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Table 3: Distribution of occupation among  
pityriasis versicolor cases ( n=100) 
Occupation No.of patients % 
Student 29 29 
Manual labourer 16 16 
Farmer 9 9 
Plumber 9 9 
Driver 7 7 
Electrician 1 1 
Housewife 8 8 
Housekeeper 1 1 
Shop Keeper 8 8 
Painter 1 1 
Tailor 7 7 
Porter 1 1 
Security 1 1 
Teacher 1 1 
Cook 1 1 
Grand Total 100 100 
 
 Among the 100 patients, 29 of them were students(29%) and  16 of 
them were working as manual labourers(16%). There were 9  farmers (9%) 
and 9 plumbers (9%). 
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Figure 3:Occupation distribution among pityriasis  
versicolor cases  ( n=100) 
 
 
 
 
 
 
 
 
 
 
Table4 :Distribution of urban and rural population  
among pityriasis versicolor patients ( n=100) 
Residence No.of Patients % 
Urban 65 65 
Rural 35 35 
Total 100 100 
 
 In this study ,65 patients (65%)  belonged to urban population while 
45patients (45%) were from  rural areas. 
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Figure 4 :Distribution of urban and rural population among pityriasis 
versicolor patients (n=100) 
 
 
 
 
 
 
 
 
Table 5:   Marital status among pityriasis  
versicolor patients (n=100) 
Marital Stage No.of Patients % 
Married 51 51 
Unmarried 49 49 
Total 100 100 
                    
 In this study, 51patients( 51%)  were married and others, 49 
patients(49%)  were unmarried. There was not much of a difference in the 
marital status of the patients.  
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Figure 5: Marital status among pityriasis  
versicolor patients (n=100) 
 
Table 6: Family history in the  
study group (n = 100) 
 
FAMILY HISTORY No.of Patients % 
Present 31 31 
Absent 69 69 
Total 100 100 
 
 Family history of similar infection was present in 31patients(31%)  and 
remaining 69 patients(69%) had no such history 
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Table 7:  Frequency of sweating among pityriasis  
versicolor patients  (n=100) 
EXCESSIVE SWEATING No.of Patients % 
Present 58 58 
Absent 42 42 
Total 100 100 
 
 History of excessive sweating was present in 58 patients (58%) while 
the remaining 42(42%)patients had no such history. 
Table 8:Frequency of occurrence of PV  in the study  
population(n =100) 
 
 
 
 
 
 
 
 
 
  O u t  o f  t h e  h u n d r e d  p a t i e n t s , 65 patients(65%) had 
pityriasis versicolor for the first time and 35patients (35%) had recurrence. 
Frequency of Occurrence No.of Patients % 
First Episode 65 65 
Recurrence 35 35 
Total 100 100 
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Figure 6: Distribution of patients with pruritus, family history and 
history of recurrence of PV in the study population (n = 100) 
 
Table 9: Duration of lesion among pityriasis versicolor patients( n=100) 
DURATION No.of Patients % 
1 Week to 1 Month 8 8 
Above 1 Month to 6 Month 64 64 
Above 6 Month to 1 year 19 19 
More than 1 year 9 9 
Total 100 100 
 
 In this study, duration of the disease between 1 month to 6 months was 
noted in 64 patients(65%), 19 patients(19%) had duration between 6 months 
to 1 year and 9 (9%) patients had disease for more than 1 year. 
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Figure 7: Duration of PV among study population( n=100) 
 
Table 10 : Symptoms among patients with PV in  
the study population (n = 100) 
SYMPTOMS No.of Patients % 
Cosmetic 68 68 
Pruritis 32 32 
Total 100 100 
 
 Out of the 100 patients, 68 patients (68%) had come due to cosmetic 
concern and 32 patients(32%) patients had pruritis. 
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Figure 8: : Symptoms among patients with PV  
in the study population (n = 100) 
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Table 11: Associated systemic conditions among  
pityriasis versicolor patients (n=100) 
SYSTEMIC 
ASSOCIATIONS 
No.of 
Patients % 
Diabetes mellitus 11 39.3 
Hypertension 7 25.0 
Chronic kidney disease 2 7.1 
Pulmonary tuberculosis 2 7.1 
Renal transplant 2 7.1 
Bronchiectasis 1 3.6 
DCLD 1 3.6 
Hypothyroidism 1 3.6 
Nephrotic Syndrome 1 3.6 
Total 28 100 
 
 Among the 100 patients, 28(28%) patients had systemic association. 
Diabetes mellitus was present in 11 patients (39.3), followed by hypertension 
in 7 patients( 25%), followed by pulmonary tuberculosis in 2 patients(7.1) 
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Figure 9: Associated systemic condition among  
pityriasis versicolor patients (n=100) 
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Table 12; Associated dermatological disorders with  
pityriasis versicolor patients (n=100) 
 
 
 
 
 
 
 
 
 Out of the hundred patients, 58 patients(58%)  had associated 
dermatological disorders, of which 21patients (21%) had seborrheic 
dermatitis, 14 patients(14%) had acne, 2 patients(2%) had candidiasis and 
lichen planus. 
ASSOCIATED DERMATOLOGICAL 
DISORDER 
No.of 
Patients 
% 
Seborrheic dermatitis 21 36.20 
Acne 14 24.13 
Dermatophytosis 11 18.97 
Candidiasis 2 3.45 
Lichen planus 2 3.45 
Congenital melanocytic naevus 1 1.72 
IGH 1 1.72 
Lichen amyloid 1 1.72 
Pompholyx 1 1.72 
Pyoderma 1 1.72 
Seborrheic keratosis 1 1.72 
Stasis dermatitis 1 1.72 
Wart 1 1.72 
Total 58 100 
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Figure10:Associated dermatological disorders  
among pityriasis versicolor patients(n=100)
 
Table 13: Distribution of site of involvement  
of pityriasis versicolor  (n=100) 
SITE OF 
INVOLVEMENT 
No.of 
Patients % 
Back 46 46 
Face & Neck 26 26 
Chest 17 17 
Arms 9 9 
Shoulder 2 2 
Total 100 100 
 
 Among the 100 patients, 46 patients had lesions over back(46%), 
followed by face and neck in 26( 26%), followed by chest in 17 patients 
(17%).  
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Figure 11 :Distribution of site of involvement of   
pityriasis versicolor patients (n=100)
 
Table 14:Extent of area of involvement among  
pityriasis versicolor (n=100) 
 
AREA OF INVOLVEMENT No.of Patients % 
<10% 2 2 
10-30% 26 26 
30%-50% 70 70 
>50% 2 2 
Total 100 100 
 
 Out of the hundred patients, 70 patients (70%) had more than 30% body 
surface area involvement, followed by more than 10% in 26 patients (26%) 
and more than 50% BSA in 2 patients(2%). 
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Figure 12 :Extent of area of involvement among  
pityriasis versicolor patients(n=100) 
 
Table 15:Distribution of clinical types of pityriasis  
versicolor among study group (n=100) 
CLINICAL TYPE No.of Patients % 
Achromic 68 68 
Chromic 23 23 
Perifollicular 12 12 
Both(mixed) 9 9 
Paranasal 2 2 
 
 In this study, out of 100 patients, 68(68%) presented with achromic 
type of PV and the remaining 32 patients (32%) had chromic type of PV. 12 
patients with achromic PV  had perifollicular type and 2 patients had 
paranasal type of PV who were adoloscents.   Nine patients had mixed type 
with both  achromic and chromic type. 
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Figure 13 :Distribution of clinical types of PV among study group  
 
Table 16:Distribution of Blood grouping & typing among pityriasis 
versicolor cases(n=100) 
BLOOG GROUPING 
& TYPING No.of Patients % 
A 52 52 
O 38 38 
B 9 9 
AB 1 1 
Total 100 100 
  
 In this study A blood group A was found in 52 patients (52%) . 38 
patients(38%) had blood group O, 9 patients(9%) had blood group B and one 
patient had AB blood group(1%)  respectively. 
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Figure14: Distribution of Blood grouping & typing  
among pityriasis versicolor cases 
 
Table17 : Isolation rate of Malassezia spp. from pityriasis versicolor 
cases in the study population (n = 100) 
 
 
 
 
 
 
 
 Out of the 100 samples of K O H  p o s i t i v e  skin scrapings, 76 (76 
%) yielded growth on Sabouraud  dextrose agar with olive oil overlay and 
the remaining 24 (24%) were culture negative. 
 
A
52%
B
9%
O
38%
AB
1%
Culture for Malassezia spp No. % 
Positive 76 76 
Negative 24 24 
Total 100 100 
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Figure 15:Isolation rate of Malassezia spp. from pityriasis versicolor 
cases in the study population (n = 100) 
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Table 18: Distribution of Malassezia species among the culture positive 
PV cases in the study population (n = 76) 
Malassezia species No.of Patients % 
M. globosa 37 48.7 
M. sympodialis 19 25 
M. furfur 8 10.5 
M. restricta 6 7.9 
M. obtusa 5 6.6 
M.sloofiae 1 1.3 
Total 76 100 
 
 Out of the 76 isolates, Malassezia globosa was the most common 
species isolated in 37 patients(48.7%) , followed by Malassezia 
sympodialis in 19 patients(25%), Malassezia furfur in 8 patients(10.5%), 
Malassezia restricta in 6(7.9%) and Malassezia obtusa in 5 patients( 6.6%) . 
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Figure16: Distribution of Malassezia species among the culture positive 
PV cases in the study population (n = 76) 
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Table 19: Correlation between type of PV and isolation rate of various 
Malassezia spp. in culture positive PV cases (n = 76) 
 
  Malassezia globosa ( 48%) was isolated from 23 patients with (23%) 
achromic type of PV and 14 patients with (14%)chromic type of PV followed 
by M. sympodialis in 12 patients(25%) with achromic type and 7 patients 
with (7%) chromic type of PV. 
 
 
 
 
CULTURE Total Chromic % Achromic % 
M. globosa 37 14 48.28 23 48.94 
M. sympodialis 19 7 24.14 12 25.53 
M. furfur 8 3 10.34 5 10.64 
M. restricta 6 1 3.45 5 10.64 
M. obtusa 5 3 10.34 2 4.26 
M.sloofiae 1 1 3.45 0 0.00 
Total 76 29 100 47 100 
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Figure 17: Correlation between type of PV and isolation rate of various 
Malassezia spp. in culture positive PV cases (n = 76) 
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Table 20: Correlation between the PV episode and Malassezia spp. 
Isolated from culture positive PV cases in the study population (n= 76) 
 
CULTURE  Total First Episode % Recurrence % 
M. globosa 37 24 52.17 13 43.33 
M. sympodialis 19 9 19.57 10 33.33 
M. furfur 8 6 13.04 2 6.67 
M. restricta 6 5 10.87 1 3.33 
M. obtuse 5 2 4.35 3 10.00 
M.sloofiae 1 0 0.00 1 3.33 
Total 76 46 100 30 100 
 
 In 24 patients (52%) with first episode PV and  in 13patients (43%)  
with recurrent lesions, M. globosa was the most common species   isolated 
followed by M. sympodialis in 9 patients (19%) with first episode and 10( 
33.3%) patients with recurrence.  
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Figure 18: Correlation between the PV episode and Malassezia spp. 
isolated from culture positive PV cases in the study population (n= 76) 
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COLOUR PLATES 
 
  
                                    
 
 
 
 
 
 
 
 
Fig.19 Clinical photograph of chromic type of  
pityriasis versicolor over back 
 
 
 
 
 
 
 
Fig.20 Clinical photograph of chromic PV over neck 
 
 
 
 
  
 
 
 
 
 
 
 
Fig.21 Clinical photograph of achromic  
type of pityriasis versicolor over face 
 
 
 
 
 
 
 
 
Fig.21 Clinical photograph of chromic type of  
pityriasis versicolor over back 
 
 
 
  
 
 
 
 
 
 
 
Fig.21 Clinical photograph of perifollicular type of pityriasis  
versicolor over back 
 
  
  
     
 
 
 
 
 
Fig.22 Clinical photograph of achromic  
type of pityriasis versicolor over arm 
 
 
  
                        
                           
 
 
 
 
Fig.21 Clinical photograph of paranasal type of  
pityriasis versicolor over face 
  
 
 
    
 
 
 
 
Fig.21 Clinical photograph of achromic type of pityriasis  
versicolor over chest and arms 
 
  
 KOH MOUNT 
                     
 
 
 
 
 
 
 
 
 
                                
 
 
 
 
 
 
 
Fig.21,22. Short , straight or angulated,  stout,  aseptate, hyaline hyphal 
elements showing ‘spaghetti and meat ball’ appearance  
 
  
  
CULTURE 
                      
 
 
 
 
 
 
 
 
 
                                           
 
 
 
 
 
Fig.23,24,25 Yeasty pasty colonies of malazeesia 
 
 
 
  
 TWEEN ASSIMILATION TEST 
 
 
 
 
 
 
 
 
 
Fig 26 Malassezia globosa  
 
 
 
 
 
 
 
 
 
 
Fig 27 Malassezia sympodialis 
  
 
 
 
 
 
 
 
 
Fig 28 Malassezia furfur 
 
 
 
 
 
 
 
 
 
 
Fig 29 Malassezia sloofiae 
 
  
GRAM STAIN 
 
 
 
 
 
 
 
 
 
Fig 30,31. Gram stain showing characteristic spores and hyphae 
 
 
 
 
 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
Fig 32. Gram stain showing characteristic spores and hyphae 
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DISCUSSION 
AGE DISTRIBUTION 
 In this study, the age group most commonly affected with pityriasis 
versicolor was 21 - 30years (43%) followed by 30 – 39 years (22%).  The 
youngest age in this study was a 13 years old male and oldest age was a 65 old 
male patient respectively. This is in accordance with the study by Sanjeev 
Grover et al   in 2003, in which 39.6% of those affected with PV belonged to 
21 – 30 years age group and 30% belonged to 31 – 40 years age group.46 In 
2002, Dutta et al  and Gatha Rao et al, also reported a 39.6%  and 30%  
incidence of PV respectively in the 21 – 30 years age group. This may be 
due to increased sebum production in the skin in this age group.17,19 
SEX DISTRIBUTION 
 In the present study, males (70%) were more commonly affected with 
pityriasis versicolor than females (30%). This is similar to the study by  
Gatha  Rao  et  al in 2002 and  Gurumohan Singh et al in 1996  in which 
they observed  73.3%  incidence and  75.3% incidence respectively.17, 47 I n  
c o n t r a s t ,  Imwidthya et al  in 1988 had observed  a higher  incidence  in 
females  which  may  be due  to the  increased cosmetic concern in the 
females residing in that part of the country 48 
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        The  higher  incidence  in  males  in  this  study,  may  be attributed  to  
increased  outdoor  activities  of  males  for  occupational  purposes, putting 
them at a higher risk of sun exposure and humidity, which favours  the 
growth of Malassezia yeasts. 
DISTRIBUTION OF OCCUPATION AND RESIDENCE 
           In this study, majority of the patients were students(29%) followed by 
manual labourers (19%). This is in accordance with studies by Sudip et al, 
where majority were students (29.09%), followed by housewives (20%) and 
manual laborers (15.46%). 49 In our study, pityriasis versicolor was common 
among urban population (65%) compared to  rural population(35%), as our 
institute caters predominantly to urban population. 
FAMILY HISTORY 
 In the present study, a positive family history of lesions similar to 
pityriasis versicolor was observed in 31% of patients. Gatha Rao et al  
observed a  positive  family  history  in  38%  of  the  PV patients. 17     
Faergemann and Fredreichson   in  1979 observed 18%  of  PV  patients  with  
history  of  similar  lesions  in  other  family members. 54 Though a positive 
family history has been noticed in more cases than chance would permit, 
whether  it is genetically  determined  or due to increased exposure   of  
t h e  family  members   to  the  causative   fungal  agent, h a s  t o  b e  
e v a l u a t e d .  
80 
 
SYMPTOMS AND SWEATING 
 In  this  study,  32  %  of  patients  had  pruritus. Similarly, in the study 
conducted by Gatha Rao et al  in 2002, 30% of the patients had pruritus. 17 
In the present study, 58% of the patients had excessive sweating. 
DURATION OF THE INFECTION 
 In the present study, the duration of lesions in the majority (64%) of  
PV patients was between 1 to 6 months. According  to Kristany  et al,  72% 
of the PV patients presented  with duration of  lesions in the 1 month – 
1year range.51 
RECURRENCE 
 In the present study, 35% of the patients had history of recurrence. 
Kristany et al observed a 26% recurrence in Indonesian population. 51 On the 
contrary, Gatha  Rao et al     observed  recurrent  PV in only  3% of the Indian 
patients.17 Pityriasis versicolor tends to be recurrent in patients living in high 
humid conditions and in those with increased outdoor activities as they are 
more prone for increased sweating. Conditions like HIV infection, 
tuberculosis, prolonged steroid intake and malignancy predispose to recurrent 
PV.  
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DERMATOLOGICAL AND SYSTEMIC ASSOCIATIONS 
 Seborrhoeic dermatitis(36.2%) was the most common dermatological 
condition associated with pityriasis versicolor followed by acne(24.13%). All 
the three conditions have Malassezia species involved in their pathogenesis. 
Crespo Erchiga  et al reported that seborrhoeic  dermatitis (40%) was the most 
common condition associated with PV followed by dermatophytosis.52 
        Among the 100 patients , 28 % patients had systemic associations. 
Diabetes mellitus was the most commonly associated systemic 
disease(39.3%), followed by hypertension( 25%) and pulmonary 
tuberculosis(7.1%). This is similar to the study conducted by Sudip et al, in 
which he found that diabetes mellitus (2.73%) was the commonest association 
but relatively this was in small proportion compared to this study.49 
BLOOD GROUPING 
       Majority of the patients had blood group A ( 52%), followed by blood 
group O (38%). This is contrary to the study conducted by Kareema et al in 
2014, blood group O was most commonly associated with PV in 74% of the 
patients followed by blood group A in 13.9% of patients and blood group B in 
10.7% of patients.53 
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EXTENT OF INVOLVEMENT 
        Majority of the patients (70%) had more than 30% BSA involvement , 
followed by more than 10% BSA (26%)  . The area of involvement is mainly 
in the  sebum rich regions of the body. 
SITE OF INVOLVEMENT 
 In this study, the major site of involvement  of pityriasis  versicolor  
was back (46%), followed by face and neck (26%). This is similar to the 
study by Gatha Rao et al who reported 70% lesions in the back of trunk. 1 7  
Gupta et al in 2001 and Imwidthaya et al  in 1988 also observed PV lesions 
to be common on the back, followed by face. 48,54 Kristany et al in 2008 
observed 76.5 % lesions were in the back of the trunk, followed by 16% in 
chest. 51 The increased involvement of the trunk, face and neck may be 
due to the presence of numerous  sebaceous glands in these sites and also 
due to the hot and humid climate prevalent in South India, resulting in 
excessive sweating in these sites, which predisposes to PV. 
CLINICAL TYPE 
 In  the  present  study,  a c h r o m i c  P V    lesions  (68%)  were  more  
common compared to the chromic lesions (23%). This correlates with the  
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studies  conducted  by  Imwidthya    et  al,   Gatha  Rao et  al   and  Crespo 
Erchiga et  al,   who reported  hypopigmented  lesions  with an incidence of  
83%,  75%  and  58% respectively.  17,48,52  Pityriacitrin and similar indole 
alkaloids produced by M. furfur and probably other Malassezia species 
induce apoptosis of human melanocytes and this is one likely explanation for 
the higher incidence of hypopigmented lesions.17,51,52 
ISOLATION RATE 
 The isolation rate of Malassezia species from clinically diagnosed 
cases of pityriasis  versicolor  was 76% in this study. Faergemann  et al  in   
1979 reported a 100% recovery rate, Dutta et al, 59% in 2002, Kindo 
et al, 68.75% in 2004. 19,50,55   The differences in the isolation rates in the 
various studies may be due to the differences in sampling techniques  and the 
use of different  media   for culture  like  SDA with olive oil, modified  
Dixon’s medium and Leeming and Notman agar and.17,54 
SPECIES ISOLATION 
 In  the  present  study,  the  most  common  species  isolated  from  
culture positive  cases  of  PV  was  M.  globosa (48.7%) followed  by  M.  
sympodialis (25%) a n d  M.  furfur (10%). This is in accordance with the 
studies by Crespo  Erchiga  et al   in 1999,  Dutta et al  in 2002, and 
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Thayikannu  et  al   in  2013  who  observed  the  most  common  isolate  to  
be M.globosa. 19,37,52    But Gupta  et al  in 2001 and   Kindo  et al    in 
2004   reported M.sympodialis  to be  the  most  common  isolate followed 
by M.globosa.54,55 Sanjeev grover et  al in 2003 reported M. furfur to be the 
most common isolate recovered from PV lesions followed by M.globosa. 46 
In this study, M. globosa was the most common species isolated from both 
achromic  (48.9%) and chromic (48.2%) types of PV.  This is in 
concordance with the studies Thayikannu et al, who also reported M. 
globosa to be the most common isolate obtained from both achromic and 
c h r o m i c  types of PV. 3 7 The higher esterase activity and lipase activity 
and hence the higher pathogenicity may be the likely cause for M. globosa 
being the most common isolated species.37,47 
           In this study, M. globosa was the most common species isolated from 
both first episode (52%) and recurrent attacks ( 43%) of PV.  Similarly Gupta  
et al  in 2001 and   Kindo  et al    in 2004,  reported M. globosa was the 
most common species isolated from both 55 % first episode and 40% 
recurrent lesions of PV followed by M.sympodialis.54,55 
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CONCLUSION 
• Pityriasis versicolor is most commonly seen in the age group between 
21 - 30years. 
• Males outnumbered the females 
• Pityriasis versicolor was more common among the students. 
• Urban population was affected more than the rural population. 
• Cosmetic concern was the main complaint 
• Duration of lesion in majority of the patients was 1 to 6 months 
• Diabetes was found to be the most common systemic associated disease 
• Seborrheic dermatitis was the most common dermatological association 
Sweating was a major predisposing factor. 
• Pityriasis versicolor was more commonly seen  in patients with blood 
group A 
• Majority of the patients had more than 30% of body surface area 
involvement. 
•  Most common site affected was back. 
• Achromic pityriasis versicolor was more common than chromic PV. 
Follicular type was seen only in patients with achromic PV. Paranasal 
type was seen in the adolescent age group 
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• Culture was positive in 76% patients 
• Malassezia globosa was the most common species isolated.  
• Malassezia globosa was the most common species isolated in 
hyperpigmented and hypopimented lesions 
• Malassezia globosa was the most common species isolated in both 
patients with first and recurrent episodes 
• Other species isolated in this study were Malassezia sympodialis, 
Malassezia furfur, Malassezia restricta, Malassezia obtusa and 
Malassezia sloofiae. 
• In this study, A blood group was the most common blood group 
associated with pityriasis versicolor which is different from the 
previous study in which O blood group is the commonest association. 
Hence, further studies in a larger population would provide more 
conclusive evidence with regard to the blood groups. 
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ANNEXURES 
  
 INFORMATION TO PARTICIPANTS 
 
Investigators :  Dr.R.Snekavalli    
                         Dr.A.Ramesh 
                         Dr.R.Madhu 
 
Name of Participant: 
 
Title: CLINICO EPIDEMIOLOGICAL AND MYCOLOGICAL STUDY 
OF PITYRIASIS VERSICOLOR 
 You are invited to take part in this study. The information in this 
document is meant to help you decide whether or not to take part. Please feel 
free to ask if you have any queries or concerns 
 We are conducting a study on CLINICO EPIDEMIOLOGICAL 
AND MYCOLOGICAL STUDY OF PITYRIASIS VERSICOLOR” 
among  patients attending Rajiv Gandhi Government General Hospital, 
Chennai  and for that your participation may be valuable to us. 
  The purpose of this study is to determine the epidemiology, clinical 
profile, predisposing factors, common causative agents of pityriasis 
versicolor. 
 In this study history of patient will be taken,examination and routine 
blood test will be taken ,fungal culture will be done. 
 The privacy of the patients in the research will be maintained 
throughout the study. In the event of any publication or presentation resulting 
from the research, no personally identifiable information will be shared. 
Taking part in this study is voluntary. You are free to decide whether to 
participate in this study or to withdraw at any time; your decision will not 
result in any loss of benefits to which you are otherwise entitled. 
The results of the special study may be intimated to you at the end of the study 
period or during the study if anything is found abnormal which may aid in the 
management or treatment. 
 
Signature of Investigator    Signature of the participant  
 
 
 
 PATIENT CONSENT FORM 
Title of the study  :   CLINICO EPIDEMIOLOGICAL AND  
     MYCOLOGICAL STUDY OF  
     PITYRIASIS VERSICOLOR 
Name of the Participant :  
Name of the Principal investigator: Dr.R.Snekavalli 
Name of the Institution : Rajiv Gandhi Government General  
Hospital, Chennai 
                                  
Documentation of the informed consent 
I ___________________________ have read the information in this form (or 
it has been read for me). I was free to ask any questions and they have been 
answered. I am over 18 years of age and exercising my free power of choice, 
hereby give my consent to be included as a participant in the study. 
1.  I have read and understood this consent form and the information 
 provided to me. 
2.  I have had the consent document explained to me. 
 
 3.  I have been explained about the nature of the study. 
4.  My rights and responsibilities have been explained to me by the  
 investigator. 
5.  I have informed the investigator of all the treatments I am taking or 
 have taken in the past 1 year  including any native (alternative) 
 treatment. 
6.  I agree to cooperate with the investigator and I will inform her 
 immediately if  I suffer unusual symptoms. 
7.  I have not participated in any research study at any time . 
8.  I am aware of the fact that I can opt out of the study at any time without 
 having to give any reason and this will not affect my future treatment in 
 this hospital. 
9.  I hereby give permission to the investigators to release the information 
 obtained from me as a result of participation in this study to the 
 sponsors, regulatory authorities,Govt agencies and IEC.I understand 
 that they are publicly presented. 
10.  My identity will be kept confidential if my data are publicly presented. 
11.  I have had my questions answered to my satisfaction. 
12.  I have decided to be in the research study 
10.  I am aware that  if I have any question during this study, I should 
contact at one of the addresses listed above. By signing this consent 
form I attest that the information given in this document has been 
 clearly explained to me and apparently understood by me. I will be 
given a copy of this consent document. 
Participant’s initials:_______________ 
For adult participants: 
Name and signature/thumb impression of the participant(or legal 
representative if participant incompetent) 
_______________                  _________________          _________________ 
Name                                      Signature                              Date 
Name and signature of impartial witness (required for illiterate patients): 
________________            __________________          _________________ 
Name                                    Signature                                  Date 
Address and contact number of the impartial witness: 
Name and Signature of the investigator or his representative obtaining 
consent: 
________________              __________________          ________________ 
Name                                      Signature                                Date 
  
  
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 PROFORMA 
Case No : 
 
Name :                                                    Age :            Sex::              OP No : 
 
Address :                                                Occupation : 
 
 
Chief Complaints: 
 
Duration :                                              Past history : previous episode single or 
muliple 
 
 
Family History :   
 
 
Marital History : 
 
 
Sexual history: 
 
 
Predisposing factors  :    Pregnanacy 
                                       Diabetes 
                                       TB 
                                       Immunosuppressive therapy 
                                       HIV 
                                       Transplant patients 
                                      Malnutrition 
                                      Endocrine diseases 
 
Associated dermatological disorders:   Acne 
                                                             Seborrhoeic dermatitis 
                                                              Psoriasis 
                                                              Dermatophytosis 
                                                              Candidiasis 
                                                              Acanthosis nigricans 
                                                              Other dermatological conditions 
                                   
General examination :    Anemia 
                                         Obesity / wt 
                                        Nutritional status 
Systemic Examination  :   CVS 
                                           RS 
                                           Abdomen 
                                           CNS 
                                           Others 
 
DERMATOLOGICAL EXAMINATION: 
 
Sie of involvement: scalp/ face/ neck/ shoulder/ front of chest/ abdomen/ arm/ 
forearm/ 
                                  Thigh/ legs/others 
                                  Palms and soles: 
                                  Mucosa: 
                                  Hair: 
 
Percentage of surface area: 
 
Type of the lesion: Achromic/ chromic/ 
                                peifollicular/plaque/popular/erythematous/pityrosporum   
                                folliculitis/others 
                              
Investigations 
 
Blood haemogram 
Blood sugar 
RFT 
LFT 
Blood lipid profile 
Blood grouping and typing 
HIV ELISA, VDRL for syphilis 
Potassium hydroxide mount 
Culture 
TREATMENT GIVEN;   Topical: 
                                          Systemic:  
 ABBREVIATIONS   
 
 AhR                          -         Aryl hydrocarbon Receptor (AhR) 
 AIDS                        -         Acquired immunodeficiency syndrome  
 
CFW                         -         Calcoflour White stain 
 
CSB                          -           Chicago sky blue 
 
DMSO                      -          Dimethyl Sulfoxide 
 
ELISA                      -         Enzyme Linked Immunosorbent Assay 
 
FFA                          -         Free fatty acids 
 
HIV                          -         Human Immunodeficiency Virus 
 HPE                          -         Histopathological Examination  
KOH                         -         Potassium hydroxide 
 
PAS                          -         Periodic Acid Schiff 
 
PFGE                        -         Pulsed Field Gel Electrophoresis 
 
PV                            -         PityriasisVersicolor 
RFLP                        -         Restriction Fragment Length Polymorphism 
 
ROS                          -         Reactive Oxygen Species  
SDA                         -         Sabouraud  Dextrose Agar 
 SD                            -         Seborrheic Dermatitis 
UV                            -         Ultraviolet 
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 KEY TO MASTER CHART 
SEX 
 M   MALE 
 F  FEMALE 
RESIDENCE 
 U  URBAN 
 R  RURAL  
FAMILY HISTORY, EXCESSIVE SWEATING, RECURRENCE 
 Y  YES 
 N  NO 
DURATION OF INFECTION 
 M  MONTH    
 Y  YEAR 
 W  WEEK  
 
 SYMPTOM 
 P  PRURITIC 
 C  COSMETIC 
SYSTEMIC ASSOCIATION 
 DM  DIABETES MELLITES 
 RT  RENAL TRANSPLANT 
 PT  PULMONARY TUBERCULOSIS 
 DCLD DECOMPENSATED LIVER DISEASE 
 CKD  CHRONIC KIDNEY DISEASE 
 HT  HYPERTENSION 
 HYP  HYPOTHYROIDISM 
 NS   NEPHROYIC SYNDROME 
 B  BRONCHIECTASIS 
 
 
 ASSOCIATED DERMATOLOGICAL DISORDER 
 SD   SEBORRHEIC DERMATITIS 
 LP   LICHEN PLANUS 
 LA  LICHEN AMYLOID 
 CMN  CONGENITAL MELANOCYTIC NEVUS 
 D   DERMATOPHYTOSIS 
 IGH  IDIOPATHIC GUTTATE HYPOMELANOSIS 
 SK   SEBORRHEIC KERATOSIS 
 STD  STASIS DERMATITIS 
TYPE OF PV 
 HYPO HYPOPIGMENTED 
  HYPER HYPERPIGMENTED 
 
 
 
 CULTURE 
 G  – Malassezia globosa 
 S - Malassezia sympodialis 
 F  – Malassezia furfur 
 SL - Malassezia sloofiae 
 R - Malassezia restricta 
 O - Malassezia obtusa 
 
 
